Patent ID: 9273017
Filing Date: 2016-03-01
CPC Classification: A61P,C07D,C07F

Claim Text:
1. A compound of the formula (I) or a pharmaceutically acceptable salt, solvate, or hydrate thereof, wherein A is selected from the group consisting of —CO—O—, —O—CO—, —NH—CO—, —CO—NH, —C═C—, —CCH ring structure B optionally contains one nitrogen atom; R2 is selected from the group consisting of a H, a (1-4C)alkyl optionally substituted with at least one fluoro atom, a (1-4C)alkoxy optionally substituted with at least one or more fluoro atom, and a halogen; and R3 is selected from the group consisting of a (1-4C)alkylene-R5 wherein the alkylene group may be substituted with a substituent selected from a (CH R4 is selected from the group consisting of H and a (1-4C)alkyl; R5 is selected from the group consisting of —OH, —PO R6 is at least one substituent, and each R6 substituent is independently selected from the group consisting of H, a (1-4C)alkyl, and an oxo; and W is selected from the group consisting of —S—, —SO—, and —SO